Literature DB >> 7527748

IgM anti-A and D SnRNP proteins and IgM anti-dsDNA are closely associated in SLE sera.

W Zhang1, M Reichlin.   

Abstract

U1RNP and Sm precipitins occur in systemic lupus erythematosus (SLE) and in overlap syndromes, while precipitins to Ro/SSA and La/SSB occur in SLE and its variants as well as Sjögren's syndrome. In studying IgM and IgG antibodies to these polypeptides by Western blot, we found the expected frequency of antibodies to the A protein of the U1RNP specificity and the D protein of the Sm specificity in sera with precipitins to U1RNP and Sm, but also found the frequent occurrence of both IgM and IgG anti-A and D in SLE sera with no precipitins, and in sera with anti-Ro/SSA and/or anti-La/SSB precipitins, but not in sera from patients with rheumatoid arthritis, polymyositis, scleroderma, or normals. We have studied the sera which bind the A and D polypeptides on Western blot to test their ability to bind native U1RNP (which contain the A and D proteins) in ELISA. The results indicate that most anti-Ro/SSA alone, anti-Ro/SSA, and anti-La/SSB sera as well as SLE sera with no precipitins react preferentially with the denatured A and D proteins. Further study of sera with IgM anti-A and D in Western blot reveals that these sera also frequently contain anti-double-stranded DNA antibodies. These results show that the anti-A and D responses, especially IgM anti-A and D, occur not only in patients with precipitating antibodies to SnRNPs, but in almost half of patients across the lupus spectrum. The extended prevalence of antibodies to the denatured A and D proteins in Western blot is associated with the cross-reaction of antibodies to dsDNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7527748     DOI: 10.1006/clin.1995.1010

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

1.  Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.

Authors:  A Mesa; J A Somarelli; W Wu; L Martinez; M B Blom; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2013-11       Impact factor: 2.911

2.  A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.

Authors:  G Riemekasten; J Marell; G Trebeljahr; R Klein; G Hausdorf; T Häupl; J Schneider-Mergener; G R Burmester; F Hiepe
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

3.  Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.

Authors:  Michael Mahler; Marvin J Fritzler; Martin Blüthner
Journal:  Arthritis Res Ther       Date:  2004-11-10       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.